Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Interferon Beta-1A
Therapeutic Area : Neurology
Study Phase : Phase I
Recipient : Centre Hospitalier Universitaire Vaudois
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase I BP Interferon (IFN) Beta-004
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 07, 2015
Lead Product(s) : Interferon Beta-1A
Therapeutic Area : Neurology
Highest Development Status : Phase I
Recipient : Centre Hospitalier Universitaire Vaudois
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Interferon Beta-1A
Therapeutic Area : Neurology
Study Phase : Phase I
Recipient : Centre Hospitalier Universitaire Vaudois
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase I BP Interferon (IFN) Beta-001
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 05, 2015
Lead Product(s) : Interferon Beta-1A
Therapeutic Area : Neurology
Highest Development Status : Phase I
Recipient : Centre Hospitalier Universitaire Vaudois
Deal Size : Inapplicable
Deal Type : Inapplicable